Skin test to see if essential tremor may progress to Parkinson's
Part of Brain & nervous system clinical trials.
This study uses a small skin sample to look for a protein linked to Parkinson's disease. It aims to help people with essential tremor understand their risk of developing Parkinson's, which could guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 85 years old.
- You have a diagnosis of essential tremor or essential tremor plus, as defined by a 2018 medical task force.
- Your tremor has lasted at least 3 years and affects both arms (or has certain additional neurological signs).
- You are willing to provide a skin sample and undergo study procedures.
- You are not taking blood thinners (anticoagulants) or certain anti-platelet medications.
- You have no history of other neurological conditions, brain injury, or abnormal brain scan (DaTscan).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for biological markers to better understand different types of essential tremor and how the condition changes over time. It may help identify who has which subtype and predict disease progression.
This trial tests a new study drug (BP1.4979) to see if it can reduce shaking in people with essential tremor. It's for people who have had arm tremors for at least 3 years and have not had surgery for tremor.
This trial is testing whether a device that gently stimulates the nerves in your arm (called non-invasive neuromodulation) can safely reduce hand tremors over a long period. It might help with activities like eating, writing, or dressing.
This study tests a special glove designed to reduce hand shaking in people with essential tremor. It may help you feel steadier with daily tasks like drinking.
This study tests a non-invasive nerve stimulation device for reducing tremors in people with Parkinson's disease or essential tremor. It follows up participants from a previous trial to see if benefits last up to 24 months.
This study is a registry for people diagnosed with essential tremor, helping doctors collect and compare information over time. It may help improve understanding of essential tremor and guide future care.
Hear when a new Essential Tremor, Movement Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.